---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-093979"
form_type: "8-K"
ticker: "JSPR"
cik: "0001788028"
company_name: "Jasper Therapeutics, Inc."
filed_at: "2026-08-26T20:15:42+00:00"
generated_at: "2026-08-26T20:17:20.252231+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Jasper Therapeutics receives Nasdaq delisting notice for equity shortfall

## Summary
- On Aug 21, 2026, Nasdaq notified Jasper it fails $2.5M stockholders' equity requirement under Rule 5550(b)(1).
- Company has 45 days (until Oct 5, 2026) to submit a compliance plan to regain compliance.
- Plans to seek stockholder approval to convert Non-Voting Convertible Preferred Stock to boost equity.
- If plan accepted, Nasdaq may grant up to 180-day extension; otherwise hearing process available.
- No immediate effect on listing; common stock continues trading on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001213900-26-093979
- form_type: 8-K
- ticker: JSPR
- cik: 0001788028
- company_name: Jasper Therapeutics, Inc.
- filed_at: 2026-08-26T20:15:42+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1788028/000121390026093979/0001213900-26-093979-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1788028/000121390026093979/ea0303509-8k_jasper.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-093979
- JSON: https://secwatch.observer/filing/0001213900-26-093979.json
- Plain text: https://secwatch.observer/filing/0001213900-26-093979.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.